查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1466126

細胞治療技術市場：按產品、製程、細胞類型和最終用戶 - 2024-2030 年全球預測

Cell Therapy Technologies Market by Product (Consumables, Equipment, Software), Process (Cell Preservation, Distribution, & Handling, Cell Processing, Process Monitoring & Quality Control), Cell Type, End-User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年細胞治療技術市場規模為194.8億美元，預計2024年將達223.1億美元，2030年將達506.9億美元，複合年成長率為14.63%。

細胞治療技術市場包括用於治療目的的細胞療法的研究、開發、生產和應用的產品、服務和技術。這包括廣泛的產品，例如消耗品（試劑、酵素、培養基）、設備（培養箱、離心機）和服務（細胞療法製造）。該領域主要由再生醫學和免疫療法的進步推動，再生醫學和免疫療法的重點是修復和替換受損的組織和細胞，以治療各種疾病和病症。細胞治療技術應用於多個領域，包括腫瘤學、心血管疾病治療、整形外科治療、自體免疫疾病管理、遺傳性遺傳疾病矯正等。癌症、糖尿病和心血管疾病等慢性疾病的全球負擔日益增加，加速了對創新治療方法的需求。此外，政府機構和私人投資者的有利資金籌措方案正在增加對細胞療法開發相關研究活動的投資。然而，細胞療法的開發和生產通常需要複雜的步驟，導致相關成本高昂，並限制了可負擔性和可用性。技術純熟勞工的短缺會影響業界的進步速度。為了克服這些挑戰，生物製藥公司和研究機構之間的策略聯盟正在迅速擴大。該行業可以透過利用人工智慧 (AI) 和機器學習 (ML) 來最佳化流程、確定細胞治療的新標靶以及利用 3D 生物列印來進一步擴大其影響範圍。

主要市場統計
基準年[2023] 194.8億美元
預測年份 [2024] 223.1億美元
預測年份 [2030] 506.9億美元
複合年成長率（%） 14.63%

產品巨量資料分析工具的出現推動了細胞治療軟體工具的採用

耗材是細胞治療各階段所需的關鍵組件，包括細胞分離、擴增、分化和儲存。主要消耗品包括試劑、培養基、血清、生長因子和維持最佳細胞生長條件所需的其他補充品。細胞治療技術中使用的設備包括在將細胞施用給患者之前用於分離、精製、擴增、分化和基因修飾細胞的設備。此類別包括反應器（一次性或可重複使用）、離心機（用於根據密度分離細胞）和流式細胞儀（用於識別不同類型的細胞）。細胞治療耗材和設備使科學家能夠在培養物中培養新細胞，用於藥物開發目的。軟體解決方案對於有效管理、分析和解釋細胞治療過程中產生的資料至關重要。這些軟體工具有助於監控品管參數、分析資料和預測治療結果。

過程細胞保存技術的進展

細胞保存對於在儲存和運輸過程中維持細胞活力和功能至關重要。保存方法（冷凍保存、玻璃化等）和培養基選擇根據細胞類型和目的而變化。細胞加工涉及從骨髓和脂肪組織等各種來源分離、修飾和富集治療細胞。此步驟對於實現所需的治療效果同時最大限度地減少移植後副作用至關重要。過程監控可確保在整個製造過程中保持關鍵的品質屬性，以滿足細胞治療方法的監管要求。品管對於評估最終治療產品並確保其安全性、有效性和純度至關重要。

細胞類型 擴大人類細胞在細胞和基因治療的用途

動物細胞廣泛應用於多種研究領域，包括藥物發現、疾病建模、毒理學研究和基礎科學研究。動物細胞是研究細胞過程和理解複雜生物系統的寶貴工具。此外，動物細胞在生產治療藥物重組蛋白的生物過程中扮演重要角色。由於幹細胞研究和再生醫學的進步，人類細胞在治療中的使用顯著增加。人源細胞已成為個人化醫療方法的重要工具，透過根據其獨特的基因組成針對特定的患者特徵來治療和預防疾病。

政府鼓勵對最終用戶研究機構投資的舉措

在醫療保健和生命科學領域，個人化醫療、再生醫學以及改善患者治療效果的持續努力等因素正在推動對細胞治療技術的需求。這些技術包括用於分離、擴增、分析、儲存和運輸細胞的複雜設備和消耗品。基於醫療保健和生命科學機構需求的偏好從臨床級試劑到高效的細胞培養系統，可促進細胞快速生長，同時保持高品質標準。該研究所主要致力於了解細胞過程、識別新的治療標靶以及開發利用細胞治療技術治療疾病的創新方法。他們的需求包括最先進的分析和數位工具，可以準確洞察各種條件下的細胞行為。

區域洞察

美國和加拿大是美洲細胞治療技術發展的主要貢獻者。這裡有完善的生物技術和製藥產業，許多研究機構都在促進該領域的創新。美國在細胞治療創新相關專利申請數量方面處於領先地位，這正在推動私人和公共機構的投資。此外，政府推動腫瘤學和遺傳疾病研究的措施和資金正在加速基因和細胞治療技術的發展。在歐洲，注重研發的歐盟國家在細胞治療技術市場中處於領先地位。多家歐洲生物技術公司在先進治療藥物（ATMP）的臨床試驗中取得了巨大成功。在亞太地區，中國、日本和印度是細胞治療技術成長最快的市場。中國已成為主要參與者，對專門從事細胞治療的生物技術公司進行了大量投資。中國的監管改革加快了臨床試驗的核准流程，並促進了細胞療法的快速商業化。日本在再生醫學研究方面的領先地位很大程度上得益於政府對該領域的積極支持。

FPNV定位矩陣

FPNV定位矩陣對於評估細胞治療技術市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標，以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估，供應商被分為四個成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對細胞治療技術市場供應商的現狀進行深入而深入的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻，以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外，該分析還提供了對該行業競爭特徵的寶貴見解，包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。這種詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略，從而在市場上獲得競爭優勢。

本報告在以下方面提供了寶貴的見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開拓：我們深入研究利潤豐厚的新興市場，並分析其在成熟細分市場的滲透率。

3. 市場多元化：提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4. 競爭評估和情報：對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況和製造能力進行全面評估。

5. 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告解決了以下關鍵問題：

1.細胞治療技術市場的市場規模與預測是多少？

2.在細胞治療技術市場的預測期間內，有哪些產品、細分市場、應用和領域需要考慮投資？

3.細胞治療技術市場的技術趨勢與法規結構是什麼？

4.細胞治療技術市場主要廠商的市場佔有率為何？

5. 進入細胞治療技術市場的適當型態和策略手段是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 全球慢性病和感染疾病的發生率正在增加
      • 增加細胞療法生產設施的 GMP 認證
      • 政府大力投資細胞研究
    • 抑制因素
      • 與細胞治療技術相關的高成本
    • 機會
      • 持續關注個人化醫療
      • iPSC 的出現作為 ES 細胞的技術替代品
    • 任務
      • 缺乏熟練的專業人員和嚴格的法規結構
  • 市場區隔分析
    • 產品：巨量資料分析工具的出現將推動細胞治療軟體工具的採用
    • 過程：細胞保存技術的進步
    • 細胞類型：人類細胞在細胞和基因治療中的使用越來越多
    • 最終用戶：政府鼓勵對研究機構投資的舉措
  • 市場擾動分析
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 價格分析
  • 技術分析
  • 專利分析
  • 貿易分析
  • 法規結構分析

第6章細胞治療技術市場：依產品

  • 消耗品
  • 裝置
  • 軟體

第7章細胞治療技術市場：依製程分類

  • 細胞儲存、分配和處理
  • 細胞處理
  • 過程監控和品管

第8章按細胞類型分類的細胞治療技術市場

  • 動物細胞
  • 人體細胞

第9章細胞治療技術市場：依最終用戶分類

  • 醫療保健和生命科學
  • 調查機構

第10章美洲細胞治療技術市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太細胞治療技術市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲細胞治療技術市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Clade Therapeutics 宣布收購 Gadeta BV
    • 投資者投資細胞療法生產，Start-UpsCerales 增資 2.55 億美元
    • NewBiologix 籌集了 5000 萬美元，用於推進基因和細胞療法製造的新技術平台
  • 戰略分析和建議

第14章競爭產品組合

  • 主要企業簡介
  • 主要產品系列
Product Code: MRR-034230D3E636

[188 Pages Report] The Cell Therapy Technologies Market size was estimated at USD 19.48 billion in 2023 and expected to reach USD 22.31 billion in 2024, at a CAGR 14.63% to reach USD 50.69 billion by 2030.

The cell therapy technologies market encompasses the products, services, and techniques employed in the research, development, production, and application of cellular therapies for therapeutic purposes. This includes a wide range of products such as consumables (reagents, enzymes, media), equipment (incubators, centrifuges), and services (cell therapy manufacturing). The field is primarily driven by advancements in regenerative medicine and immunotherapies that focus on repairing or replacing damaged tissue or cells to treat various diseases and disorders. Cell therapy technologies find applications in multiple areas such as oncology, cardiovascular disease treatment, orthopedic treatments, autoimmune disorders management, and inherited genetic disorders correction. The increasing global burden of chronic diseases such cancer, diabetes and cardiovascular disorders has accelerated the demand for innovative therapies. Additionally, favorable funding scenarios from government agencies and private investors have led to increased investments in research activities related to cell therapy development. However, the development and production of cell therapies often require complex procedures, which result in high associated costs, limiting their affordability and accessibility. A dearth of skilled workers may affect the rate at which advancements are made within the industry. Strategic alliances among biopharmaceutical companies and research institutes are rapidly expanding to overcome such challenges. Leveraging artificial intelligence (AI) and machine learning (ML) to optimize processes or identify new targets for cellular therapies and utilization of 3D bioprinting can further expand the scope of the industry.

KEY MARKET STATISTICS
Base Year [2023] USD 19.48 billion
Estimated Year [2024] USD 22.31 billion
Forecast Year [2030] USD 50.69 billion
CAGR (%) 14.63%

Product: The advent of big data analytics tools driving the adoption of software tools for cell therapies

Consumables are essential components required during the various stages of cell therapy procedures, such as cell isolation, expansion, differentiation, and preservation. Key consumables include reagents, media, sera, growth factors, and other supplements needed to maintain optimal cell growth conditions. Equipment used in cell therapy technologies includes devices for isolation, purification, expansion, differentiation, or genetic modification of cells before administering them to patients. This category comprises bioreactors (single-use or reusable), centrifuges (for separating cells based on density), and flow cytometers (for identifying different types of cells). Cell therapy consumables and equipment enable scientists to grow new cells in the culture media for the purpose of drug development. Software solutions are critical to the effective management, analysis, and interpretation of data generated during cell therapy procedures. These software tools assist in monitoring quality control parameters, data analysis, and predicting treatment outcomes.

Process: Advancements in cell preservation technologies

Cell preservation is vital for maintaining the viability and functionality of cells during storage and transportation. The selection of preservation methods (such as cryopreservation or vitrification) and media depends on the cell type and intended application. Cell processing involves the isolation, modification, and concentration of therapeutic cells from various sources, such as bone marrow or adipose tissue. This step is crucial for achieving desired therapeutic effects while minimizing adverse reactions post-transplantation. Process monitoring ensures that critical quality attributes are maintained throughout manufacturing processes to meet regulatory requirements for cell-based therapies. Quality control is critical for evaluating the final therapeutic product and ensuring its safety, efficacy, and purity.

Cell type: Rising utilization of human cells in cell and gene therapies

Animal cells are widely used in various research areas, including drug discovery, disease modeling, toxicology studies, and basic science research. They serve as valuable tools in studying cellular processes and understanding complex biological systems. Moreover, animal cells play a significant role in bioprocessing for the production of recombinant proteins for therapeutics. The use of human cells in therapy has increased significantly due to advancements in stem cell research and regenerative medicine. Human-derived cells have become essential tools for personalized medicine approaches that aim to treat or prevent diseases by targeting specific patient profiles based on their unique genetic makeup.

End user: Government initiatives to propel investments in research institutes

In the healthcare and life science sector, the need for cell therapy technologies has been increasing due to factors such as personalized medicine, regenerative medicine, and the ongoing drive to improve patient outcomes. These technologies include advanced equipment and consumables used in cell isolation, expansion, analysis, storage, and transportation. Need-based preferences for healthcare and life science organizations range from clinical-grade reagents to efficient cell culture systems that promote rapid cell growth while maintaining high-quality standards. Research institutes primarily focus on understanding cellular processes, identifying new therapeutic targets, and developing innovative approaches for disease treatment using cell therapy technologies. Their needs include cutting-edge analytical and digital tools that provide accurate insights into cellular behavior under various conditions.

Regional Insights

The United States and Canada are major contributors to the growth of cell therapy technologies in the Americas. The presence of established biotechnology and pharmaceutical industries, along with numerous research institutions, drives innovation in this sector. The U.S. leads in patents filed for cell therapy innovations, which encourages investments from private and public entities. Furthermore, government initiatives and funding to propel research for oncology and genetic diseases have accelerated the development of gene and cell therapy technologies. In Europe, the European Union (EU) countries lead the market for cell therapy technologies with a strong focus on research and development. Several European biotech firms have made significant progress in clinical trials for advanced therapeutic medicinal products (ATMPs). China, Japan, and India are fast-growing markets for cell therapy technologies within the Asia Pacific region. China has established itself as a major player due to its considerable investment in biotech companies focused on cellular therapies. Chinese regulatory reforms have expedited approval processes for clinical trials, enabling rapid commercialization of cell therapies. Japan leads in regenerative medicine research primarily because of its government's proactive support for the sector.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Cell Therapy Technologies Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Cell Therapy Technologies Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Cell Therapy Technologies Market, highlighting leading vendors and their innovative profiles. These include Anterogen Co., Ltd., Atara Biotherapeutics by FUJIFILM Corporation, Athersys, Inc., Becton, Dickinson and Company, Bluebird Bio, Inc., Bristol-Myers Squibb Company, Cellectis SA, Danaher Corporation, ElevateBio, Gamida Cell, GE Healthcare, Gilead Sciences, Inc., JCR Pharmaceuticals Co., Ltd., Johnson & Johnson Services, Inc., Lonza Group Ltd., Merck KGaA, Miltenyi Biotec B.V. & Co. KG, Novartis AG, Sartorius AG, STEMCELL Technologies Inc., Takeda Pharmaceutical Company Limited, Tego Science, Terumo Bct, Inc., Thermo Fisher Scientific, Inc., and Vericel Corporation.

Market Segmentation & Coverage

This research report categorizes the Cell Therapy Technologies Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Consumables
    • Equipment
      • Cell Processing Equipment
      • Single-Use Equipment
    • Software
  • Process
    • Cell Preservation, Distribution, & Handling
    • Cell Processing
    • Process Monitoring & Quality Control
  • Cell Type
    • Animal Cells
    • Human Cells
      • Differentiated Cells
      • Stem Cells
  • End-User
    • Healthcare & Life Science
    • Research Institutes
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Cell Therapy Technologies Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Cell Therapy Technologies Market?

3. What are the technology trends and regulatory frameworks in the Cell Therapy Technologies Market?

4. What is the market share of the leading vendors in the Cell Therapy Technologies Market?

5. Which modes and strategic moves are suitable for entering the Cell Therapy Technologies Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing incidence of chronic diseases and infections globally
      • 5.1.1.2. Rising GMP certifications for cell therapy production facilities
      • 5.1.1.3. Surge in government initiatives through investments in cell-based research
    • 5.1.2. Restraints
      • 5.1.2.1. High costs associated with cell therapy technologies
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing focus on personalized medicine
      • 5.1.3.2. Emergence of iPSCs as an alternative to ESCs in technologies
    • 5.1.4. Challenges
      • 5.1.4.1. Dearth of skilled professionals and stringent regulatory framework
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: The advent of big data analytics tools driving the adoption of software tools for cell therapies
    • 5.2.2. Process: Advancements in cell preservation technologies
    • 5.2.3. Cell type: Rising utilization of human cells in cell and gene therapies
    • 5.2.4. End user: Government initiatives to propel investments in research institutes
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Cell Therapy Technologies Market, by Product

  • 6.1. Introduction
  • 6.2. Consumables
  • 6.3. Equipment
  • 6.4. Software

7. Cell Therapy Technologies Market, by Process

  • 7.1. Introduction
  • 7.2. Cell Preservation, Distribution, & Handling
  • 7.3. Cell Processing
  • 7.4. Process Monitoring & Quality Control

8. Cell Therapy Technologies Market, by Cell Type

  • 8.1. Introduction
  • 8.2. Animal Cells
  • 8.3. Human Cells

9. Cell Therapy Technologies Market, by End-User

  • 9.1. Introduction
  • 9.2. Healthcare & Life Science
  • 9.3. Research Institutes

10. Americas Cell Therapy Technologies Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Cell Therapy Technologies Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Cell Therapy Technologies Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Clade Therapeutics Announces the Acquisition of Gadeta B.V.
    • 13.3.2. Startup Cellares adds USD 255 million as investors pour cash into cell therapy production
    • 13.3.3. NewBiologix Launches with USD 50 million to Advance Novel Technology Platform for the Manufacturing of Gene and Cell Therapies
  • 13.4. Strategy Analysis & Recommendation

14. Competitive Portfolio

  • 14.1. Key Company Profiles
  • 14.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. CELL THERAPY TECHNOLOGIES MARKET RESEARCH PROCESS
  • FIGURE 2. CELL THERAPY TECHNOLOGIES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. CELL THERAPY TECHNOLOGIES MARKET DYNAMICS
  • FIGURE 7. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 14. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS CELL THERAPY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. AMERICAS CELL THERAPY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 18. UNITED STATES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC CELL THERAPY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC CELL THERAPY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. CELL THERAPY TECHNOLOGIES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 24. CELL THERAPY TECHNOLOGIES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CELL THERAPY TECHNOLOGIES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CONSUMABLES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL PROCESSING EQUIPMENT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL PROCESSING EQUIPMENT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY SINGLE-USE EQUIPMENT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY SINGLE-USE EQUIPMENT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY SOFTWARE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL PRESERVATION, DISTRIBUTION, & HANDLING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL PRESERVATION, DISTRIBUTION, & HANDLING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL PROCESSING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL PROCESSING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS MONITORING & QUALITY CONTROL, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS MONITORING & QUALITY CONTROL, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY ANIMAL CELLS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY ANIMAL CELLS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY DIFFERENTIATED CELLS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY DIFFERENTIATED CELLS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY STEM CELLS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY STEM CELLS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HEALTHCARE & LIFE SCIENCE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HEALTHCARE & LIFE SCIENCE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 45. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 46. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 47. AMERICAS CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 48. AMERICAS CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 49. AMERICAS CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 50. AMERICAS CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 51. AMERICAS CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
  • TABLE 52. AMERICAS CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
  • TABLE 53. AMERICAS CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 54. AMERICAS CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 55. AMERICAS CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2023 (USD MILLION)
  • TABLE 56. AMERICAS CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2024-2030 (USD MILLION)
  • TABLE 57. AMERICAS CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 58. AMERICAS CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 59. AMERICAS CELL THERAPY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 60. AMERICAS CELL THERAPY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 61. ARGENTINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 62. ARGENTINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 63. ARGENTINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 64. ARGENTINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 65. ARGENTINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
  • TABLE 66. ARGENTINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
  • TABLE 67. ARGENTINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 68. ARGENTINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 69. ARGENTINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2023 (USD MILLION)
  • TABLE 70. ARGENTINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2024-2030 (USD MILLION)
  • TABLE 71. ARGENTINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 72. ARGENTINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 73. BRAZIL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 74. BRAZIL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 75. BRAZIL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 76. BRAZIL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 77. BRAZIL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
  • TABLE 78. BRAZIL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
  • TABLE 79. BRAZIL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 80. BRAZIL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 81. BRAZIL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2023 (USD MILLION)
  • TABLE 82. BRAZIL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2024-2030 (USD MILLION)
  • TABLE 83. BRAZIL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 84. BRAZIL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 85. CANADA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 86. CANADA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 87. CANADA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 88. CANADA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 89. CANADA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
  • TABLE 90. CANADA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
  • TABLE 91. CANADA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 92. CANADA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 93. CANADA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2023 (USD MILLION)
  • TABLE 94. CANADA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2024-2030 (USD MILLION)
  • TABLE 95. CANADA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 96. CANADA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 97. MEXICO CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 98. MEXICO CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 99. MEXICO CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 100. MEXICO CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 101. MEXICO CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
  • TABLE 102. MEXICO CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
  • TABLE 103. MEXICO CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 104. MEXICO CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 105. MEXICO CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2023 (USD MILLION)
  • TABLE 106. MEXICO CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2024-2030 (USD MILLION)
  • TABLE 107. MEXICO CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 108. MEXICO CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 109. UNITED STATES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 110. UNITED STATES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 111. UNITED STATES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 112. UNITED STATES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 113. UNITED STATES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
  • TABLE 114. UNITED STATES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
  • TABLE 115. UNITED STATES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 116. UNITED STATES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 117. UNITED STATES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2023 (USD MILLION)
  • TABLE 118. UNITED STATES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2024-2030 (USD MILLION)
  • TABLE 119. UNITED STATES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 120. UNITED STATES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 121. UNITED STATES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 122. UNITED STATES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 123. ASIA-PACIFIC CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 125. ASIA-PACIFIC CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
  • TABLE 128. ASIA-PACIFIC CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 131. ASIA-PACIFIC CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2023 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2024-2030 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 134. ASIA-PACIFIC CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC CELL THERAPY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC CELL THERAPY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 137. AUSTRALIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 138. AUSTRALIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 139. AUSTRALIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 140. AUSTRALIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 141. AUSTRALIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
  • TABLE 142. AUSTRALIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
  • TABLE 143. AUSTRALIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 144. AUSTRALIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 145. AUSTRALIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2023 (USD MILLION)
  • TABLE 146. AUSTRALIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2024-2030 (USD MILLION)
  • TABLE 147. AUSTRALIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 148. AUSTRALIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 149. CHINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 150. CHINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 151. CHINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 152. CHINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 153. CHINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
  • TABLE 154. CHINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
  • TABLE 155. CHINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 156. CHINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 157. CHINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2023 (USD MILLION)
  • TABLE 158. CHINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2024-2030 (USD MILLION)
  • TABLE 159. CHINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 160. CHINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 161. INDIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 162. INDIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 163. INDIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 164. INDIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 165. INDIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
  • TABLE 166. INDIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
  • TABLE 167. INDIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 168. INDIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 169. INDIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2023 (USD MILLION)
  • TABLE 170. INDIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2024-2030 (USD MILLION)
  • TABLE 171. INDIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 172. INDIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 173. INDONESIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 174. INDONESIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 175. INDONESIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 176. INDONESIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 177. INDONESIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
  • TABLE 178. INDONESIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
  • TABLE 179. INDONESIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 180. INDONESIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 181. INDONESIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2023 (USD MILLION)
  • TABLE 182. INDONESIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2024-2030 (USD MILLION)
  • TABLE 183. INDONESIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 184. INDONESIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 185. JAPAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 186. JAPAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 187. JAPAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 188. JAPAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 189. JAPAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
  • TABLE 190. JAPAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
  • TABLE 191. JAPAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 192. JAPAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 193. JAPAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2023 (USD MILLION)
  • TABLE 194. JAPAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2024-2030 (USD MILLION)
  • TABLE 195. JAPAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 196. JAPAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 197. MALAYSIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 198. MALAYSIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 199. MALAYSIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 200. MALAYSIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 201. MALAYSIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
  • TABLE 202. MALAYSIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
  • TABLE 203. MALAYSIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 204. MALAYSIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 205. MALAYSIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2023 (USD MILLION)
  • TABLE 206. MALAYSIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2024-2030 (USD MILLION)
  • TABLE 207. MALAYSIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 208. MALAYSIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 209. PHILIPPINES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 210. PHILIPPINES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 211. PHILIPPINES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 212. PHILIPPINES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 213. PHILIPPINES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
  • TABLE 214. PHILIPPINES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
  • TABLE 215. PHILIPPINES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 216. PHILIPPINES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 217. PHILIPPINES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2023 (USD MILLION)
  • TABLE 218. PHILIPPINES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2024-2030 (USD MILLION)
  • TABLE 219. PHILIPPINES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 220. PHILIPPINES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 221. SINGAPORE CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 222. SINGAPORE CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 223. SINGAPORE CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 224. SINGAPORE CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 225. SINGAPORE CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
  • TABLE 226. SINGAPORE CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
  • TABLE 227. SINGAPORE CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 228. SINGAPORE CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 229. SINGAPORE CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2023 (USD MILLION)
  • TABLE 230. SINGAPORE CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2024-2030 (USD MILLION)
  • TABLE 231. SINGAPORE CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 232. SINGAPORE CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 233. SOUTH KOREA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 234. SOUTH KOREA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 235. SOUTH KOREA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 236. SOUTH KOREA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 237. SOUTH KOREA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
  • TABLE 238. SOUTH KOREA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
  • TABLE 239. SOUTH KOREA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 240. SOUTH KOREA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 241. SOUTH KOREA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2023 (USD MILLION)
  • TABLE 242. SOUTH KOREA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2024-2030 (USD MILLION)
  • TABLE 243. SOUTH KOREA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 244. SOUTH KOREA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 245. TAIWAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 246. TAIWAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 247. TAIWAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 248. TAIWAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 249. TAIWAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
  • TABLE 250. TAIWAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
  • TABLE 251. TAIWAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 252. TAIWAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 253. TAIWAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2023 (USD MILLION)
  • TABLE 254. TAIWAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2024-2030 (USD MILLION)
  • TABLE 255. TAIWAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 256. TAIWAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 257. THAILAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 258. THAILAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 259. THAILAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 260. THAILAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 261. THAILAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
  • TABLE 262. THAILAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
  • TABLE 263. THAILAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 264. THAILAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 265. THAILAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2023 (USD MILLION)
  • TABLE 266. THAILAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2024-2030 (USD MILLION)
  • TABLE 267. THAILAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 268. THAILAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 269. VIETNAM CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 270. VIETNAM CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 271. VIETNAM CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 272. VIETNAM CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 273. VIETNAM CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
  • TABLE 274. VIETNAM CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
  • TABLE 275. VIETNAM CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 276. VIETNAM CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 277. VIETNAM CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2023 (USD MILLION)
  • TABLE 278. VIETNAM CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2024-2030 (USD MILLION)
  • TABLE 279. VIETNAM CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 280. VIETNAM CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 281. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 282. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 283. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 284. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 285. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
  • TABLE 286. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
  • TABLE 287. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 288. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 289. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2023 (USD MILLION)
  • TABLE 290. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2024-2030 (USD MILLION)
  • TABLE 291. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 292. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 293. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 294. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 295. DENMARK CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 296. DENMARK CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 297. DENMARK CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 298. DENMARK CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 299. DENMARK CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
  • TABLE 300. DENMARK CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
  • TABLE 301. DENMARK CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 302. DENMARK CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 303. DENMARK CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2023 (USD MILLION)
  • TABLE 304. DENMARK CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2024-2030 (USD MILLION)
  • TABLE 305. DENMARK CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 306. DENMARK CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 307. EGYPT CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 308. EGYPT CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 309. EGYPT CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 310. EGYPT CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 311. EGYPT CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
  • TABLE 312. EGYPT CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
  • TABLE 313. EGYPT CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 314. EGYPT CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 315. EGYPT CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2023 (USD MILLION)
  • TABLE 316. EGYPT CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2024-2030 (USD MILLION)
  • TABLE 317. EGYPT CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 318. EGYPT CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 319. FINLAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 320. FINLAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 321. FINLAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 322. FINLAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 323. FINLAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
  • TABLE 324. FINLAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
  • TABLE 325. FINLAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 326. FINLAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 327. FINLAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2023 (USD MILLION)
  • TABLE 328. FINLAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2024-2030 (USD MILLION)
  • TABLE 329. FINLAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 330. FINLAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 331. FRANCE CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 332. FRANCE CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 333. FRANCE CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 334. FRANCE CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)

TABLE 33